Immunization Reminder Bracelets Study
NCT03310762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1445
Last updated 2019-02-19
Summary
Pakistan has one of the highest infant mortality rates in the world in part, due to the low coverage (54%) for all basic vaccinations. Low uptake, lack of awareness among parents to complete the recommended immunization schedule and inability to remember vaccine appointments are some of the key factors hindering improvement in uptake of immunization services. On the supply side, ineffective methods to track children's' vaccine doses means that there is no reliable mechanism to verify vaccine administration and estimate accurate immunization coverage.
This study proposes to develop and test two types of silicon bracelets for children to stimulate immunization demand and simultaneously address supply side verification issues. These bracelets use a combination of numbers and symbols to denote the age of the child and due vaccines and are designed for illiterate or uneducated mothers; are low-cost and adaptable to most local settings. At the time of vaccine administration, the appropriate symbol denoting the vaccine on the bracelets is punched and therefore the bracelets can serve as effective reminders for mothers for timely immunization of their child and as a tool for vaccinators to verify vaccine administration and coverage.
An individually randomized, three-arm parallel group design randomized control trial will be conducted with equal allocation in the two treatment groups and control group. Children in intervention group A will receive the simple silicon bracelets, children in intervention group B will receive the bracelets developed by Alma Sana Inc. and children in the Control group will not receive any intervention. The impact of these immunization reminder bracelets on immunization coverage and timeliness will be evaluated through a randomized control trial (RCT) across 4 immunization centers in Karachi. To evaluate the bracelets' impact, variables of interest-coverage and timeliness rates of pentavalent-3/PCV-3/polio-3 and Measles 1 vaccine will be compared between Group A and the Control Group and Group B and the Control Group.
Proposed results include increase in immunization coverage and timeliness of Pentavalent-3/Pneumococcal Conjugate Vaccine (PCV-3)/Polio-3 and Measles-1 in the intervention versus control group.
The study will provide evidence of the bracelet's effectiveness for the global health community and provide a simple tool for strengthening routine immunization efforts in Pakistan.
Conditions
- Immunization; Infection
Interventions
- OTHER
-
Alma Sana Bracelet
Every time a child receives a vaccine, vaccinators will hole punchers to perforate shapes denoting the particular vaccine a child has received.
- OTHER
-
Simple Silicon Bracelet
Every time a child receives a vaccine, vaccinators will hole punchers to perforate shapes denoting the particular vaccine a child has received.
Sponsors & Collaborators
-
Harvard Medical School (HMS and HSDM)
collaborator OTHER -
Interactive Research and Development
lead OTHER
Principal Investigators
-
Danya A Siddiqi, MSc · Interactive Research and Development
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-07-19
- Primary Completion
- 2018-10-16
- Completion
- 2018-10-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan
NCT03286803 ·Status: UNKNOWN ·Phase: PHASE4
-
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
NCT03821441 ·Status: UNKNOWN ·Phase: PHASE3
-
Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3
NCT01586572 ·Status: COMPLETED ·Phase: NA
-
The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children
NCT02002065 ·Status: COMPLETED
-
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
NCT00835380 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Controlled Trial of Measles Vaccination Schedule
NCT03170765 ·Status: UNKNOWN ·Phase: NA
-
Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
NCT00453570 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule
NCT00315055 ·Status: COMPLETED ·Phase: PHASE3
-
SMS Mobile Technology for Vaccine Coverage and Acceptance
NCT01663636 ·Status: COMPLETED
-
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
NCT00619502 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months
NCT03671616 ·Status: COMPLETED ·Phase: PHASE3
-
IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.
NCT01695798 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine
NCT02445703 ·Status: COMPLETED ·Phase: PHASE4
-
Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762 ·Status: WITHDRAWN
-
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
NCT06978621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
NCT05613127 ·Status: UNKNOWN ·Phase: PHASE3
-
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
NCT00404651 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
NCT04072276 ·Status: COMPLETED
-
Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.
NCT02697474 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
NCT01307436 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
NCT00534833 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NCT06605755 ·Status: RECRUITING ·Phase: NA
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
NCT00287092 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
NCT06298708 ·Status: COMPLETED ·Phase: PHASE3